Savvy Trades and Investments

[researcher59]

OGN -.71 to 16.54, the relentless selloff continues. It keeps getting cheaper every day so I'm not feeling very motivated to add to my small position. The latest news on "The Fly" was positive - new analyst coverage with an "Overweight" rating -

fly (9/21) -

Barclays analyst Balaji Prasad initiated coverage of Organon with an Overweight rating and $28 price target. The firm says Organon is a global play and leader in women's specialty. The company is seeing "rapid growth" in biosimilars that can together offset the decline in its brands portfolio, the analyst tells investors in a research note.